Community Advisory Board

Readers Rep

Markets:

Overview

News

Currencies

International

Treasuries

Solid Biosciences Inc. - Common Stock (NQ:SLDB)

9.250 +0.390 (+4.40%)

Streaming Delayed Price Updated: 10:51 AM EDT, Jun 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Solid Biosciences Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Solid Biosciences Inc. (NASDAQ: SLDB) Near the Top of Equities by Percentage Gain on 11/15

November 15, 2023

Via Investor Brand Network

Why CorMedix Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket ↗

November 15, 2023

Shares of CorMedix Inc. (NASDAQ: CRMD) surged in pre-market trading as the company posted a narrower-than-expected third-quarter loss. Cormedix posted a loss of 17 cents per share for the third...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 15, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 15, 2023

It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news worth reading about on Wednesday!

Via InvestorPlace

Solid Biosciences: Q1 Earnings Insights ↗

May 11, 2023

Via Benzinga

Solid Biosciences Touts Encouraging Preclinical Data From Potential Duchenne Gene Therapy ↗

October 17, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

October 05, 2023

On Thursday, 369 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

October 02, 2023

On Monday, 369 companies set new 52-week lows.

Via Benzinga

Are Gene Therapy Stocks The Market's Next Big Winners?

September 25, 2023

Biotechs Sarepta and BioMarin are among companies advancing cutting-edge gene therapies, although those treatments can come with a $2 million or more price.

Via MarketBeat

Topics Artificial Intelligence

Stocks That Hit 52-Week Lows On Tuesday ↗

September 26, 2023

On Tuesday, 386 stocks made new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023 ↗

September 22, 2023

Via Benzinga

Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated ↗

July 28, 2023

Earlier today, Biogen Inc (NASDAQ: BIIB) agreed to acquire Reata Pharmaceuticals Inc (NASDAQ: RETA) for $172.50 per share in cash, reflecting an enterprise value of

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

September 21, 2023

During the session on Thursday, 461 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

September 19, 2023

During Tuesday's session, 275 companies made new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

March 06, 2023

On Monday, 36 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 08, 2023

Friday's session saw 225 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 24, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

September 07, 2023

On Thursday, 283 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 21, 2023

On Tuesday, 74 companies achieved new lows for the year.

Via Benzinga

SOLID BIOSCIENCES INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Solid Biosciences Inc. - SLDB

November 12, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Stocks That Hit 52-Week Lows On Friday ↗

October 28, 2022

During Friday, 125 stocks hit new 52-week lows.

Via Benzinga

7 Sizzling Stocks That Are Oblivious to the Manic Market ↗

October 20, 2022

While some stocks to buy have performed surprisingly well recently, they remain relatively obscure, providing a contrarian opportunity.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022 ↗

October 17, 2022

Upgrades

Via Benzinga

SOLID BIOSCIENCES INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Solid Biosciences Inc. - SLDB

September 30, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session ↗

September 30, 2022

Gainers

Via Benzinga

SLDB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Solid Biosciences Inc. Is Fair to Shareholders

September 30, 2022

From Halper Sadeh LLC

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 30, 2022

Gainers Ainos (NASDAQ:AIMD) shares increased by 46.4% to $2.02 during Friday's pre-market session. The market value of their outstanding shares is at $39.3 million.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 22, 2022

Gainers Spero Therapeutics (NASDAQ:SPRO) shares moved upwards by 122.7% to $1.83 during Thursday's pre-market session. The market value of their outstanding shares is at $64.1 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 21, 2022

Gainers Pulmatrix (NASDAQ:PULM) shares rose 11.9% to $4.3 during Wednesday's after-market session. The company's market cap stands at $14.5 million.

Via Benzinga

Solid Biosciences Earnings Perspective: Return On Capital Employed ↗

September 06, 2022

According to Benzinga Pro data, during Q2, Solid Biosciences (NASDAQ:SLDB) posted sales of $6.17 million. Earnings were up 0.93%, but Solid Biosciences still reported an overall loss of $25.09...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

About Us

Solid Biosciences Inc. - Common Stock (NQ:SLDB)

All News about Solid Biosciences Inc. - Common Stock